FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Lactate Injection, USP
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology

Hospira, Inc. (New 01/09/2020)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
50 mEq/10 mL (5 mEq/10 mL); Single Dose Plastic Fliptop Vial (NDC 00409-6664-02) 01/09/2020 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English